The joint effects of arsenic and risk diplotypes of insulin-like growth factor binding protein-3 in renal cell carcinoma.

[1]  Y. Hsueh,et al.  Arsenic methylation capacity and obesity are associated with insulin resistance in obese children and adolescents. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  J. Cheville,et al.  Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinoma. , 2014, The Journal of urology.

[3]  Lourdes,et al.  Supplemental Material Associations between Arsenic Species in Exfoliated Urothelial Cells and Prevalence of Diabetes among Residents of Chihuahua , Mexico , 2014 .

[4]  S. Cha,et al.  Insulin Receptor Expression in Clear Cell Renal Cell Carcinoma and Its Relation to Prognosis , 2014, Yonsei medical journal.

[5]  T. Mashtare,et al.  Management of Comorbidities in Diabetics With Renal Cell Carcinoma , 2014, Journal of pharmacy practice.

[6]  R. Figlin,et al.  Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: New strategies for overcoming resistance to VEGFR and mTORC1 inhibitors , 2013, International journal of cancer.

[7]  S. Byun,et al.  Multi-Institutional Analysis of Localized Renal Cell Carcinoma that Demonstrates the Impact of Diabetic Status on Prognosis After Nephrectomy , 2013, Annals of Surgical Oncology.

[8]  Young Seol Kim,et al.  Arsenic Exposure and Prevalence of Diabetes Mellitus in Korean Adults , 2013, Journal of Korean medical science.

[9]  Xiangyi Zheng,et al.  Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies , 2013, PloS one.

[10]  Xian-jin Wang,et al.  Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies , 2013, PloS one.

[11]  Tomáš Matoušek,et al.  Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets. , 2013, Toxicology and applied pharmacology.

[12]  Yingying Luo,et al.  Association study of a common variant near IRS1 with type 2 diabetes mellitus in Chinese Han population , 2013, Endocrine.

[13]  C. la Vecchia,et al.  Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  Y. Hsueh,et al.  Urinary total arsenic and 8-hydroxydeoxyguanosine are associated with renal cell carcinoma in an area without obvious arsenic exposure. , 2012, Toxicology and applied pharmacology.

[15]  J. Virtamo,et al.  Modifying effects of alcohol on the postprandial glucose and insulin responses in healthy subjects. , 2012, The American journal of clinical nutrition.

[16]  R. Lamuela-Raventós,et al.  Wine, Beer, Alcohol and Polyphenols on Cardiovascular Disease and Cancer , 2012, Nutrients.

[17]  A. Milton,et al.  Association between type 2 diabetes and chronic arsenic exposure in drinking water: A cross sectional study in Bangladesh , 2012, Environmental Health.

[18]  SuJin Song,et al.  Alcohol intake and renal cell cancer risk: a meta-analysis , 2012, British Journal of Cancer.

[19]  Y. Hsueh,et al.  The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area. , 2011, Toxicology and applied pharmacology.

[20]  M. Safarinejad.  Insulin‐like growth factor binding protein‐3 (IGFBP‐3) gene variants are associated with renal cell carcinoma , 2011, BJU international.

[21]  Liping Xie,et al.  Alcohol intake and risk of renal cell carcinoma: a meta-analysis of published case-control studies , 2011, Archives of medical science : AMS.

[22]  Y. Hsueh,et al.  Effect of urinary total arsenic level and estimated glomerular filtration rate on the risk of renal cell carcinoma in a low arsenic exposure area. , 2011, The Journal of urology.

[23]  W. Willett,et al.  Type 2 Diabetes and the Risk of Renal Cell Cancer in Women , 2011, Diabetes Care.

[24]  Gang Wu,et al.  Association between insulin-like growth factor binding protein-3 promoter polymorphism of -1590 C>A and lung cancer susceptibility in a Chinese Han population. , 2011, Genetic testing and molecular biomarkers.

[25]  M. Gazouli,et al.  Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population , 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[26]  S. Larsson,et al.  Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies , 2011, Diabetologia.

[27]  M. Bates,et al.  Kidney Cancer Mortality: Fifty-year Latency Patterns Related to Arsenic Exposure , 2010, Epidemiology.

[28]  Jie Liu,et al.  Fetal arsenic exposure appears to facilitate endocrine disruption by postnatal diethylstilbestrol in neonatal mouse adrenal. , 2009, Chemico-biological interactions.

[29]  H. Werner,et al.  Insulin analogues display IGF‐I‐like mitogenic and anti‐apoptotic activities in cultured cancer cells , 2009, Diabetes/metabolism research and reviews.

[30]  E. Shin,et al.  Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population. , 2008, Lung cancer.

[31]  R. DePinho,et al.  Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. , 2008, Cell metabolism.

[32]  A. Barchowsky,et al.  Positive signaling interactions between arsenic and ethanol for angiogenic gene induction in human microvascular endothelial cells. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[33]  G. Blackburn,et al.  Symposium introduction: metabolic syndrome and the onset of cancer. , 2007, The American journal of clinical nutrition.

[34]  B. Henderson,et al.  Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population. , 2007, The Journal of clinical endocrinology and metabolism.

[35]  R. Wolff,et al.  Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States , 2007, Breast Cancer Research and Treatment.

[36]  W. Willett,et al.  Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. , 2007, Journal of the National Cancer Institute.

[37]  C. la Vecchia,et al.  Lifetime physical activity and the risk of renal cell cancer , 2007, International journal of cancer.

[38]  V. Darley-Usmar,et al.  Mechanism by which alcohol and wine polyphenols affect coronary heart disease risk. , 2007, Annals of epidemiology.

[39]  M. Esteller.  Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.

[40]  A. Rosendahl,et al.  IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells. , 2006, Kidney international.

[41]  K. Højlund,et al.  Impaired glycogen synthase activity and mitochondrial dysfunction in skeletal muscle: markers or mediators of insulin resistance in type 2 diabetes? , 2006, Current diabetes reviews.

[42]  D. Ge,et al.  Association analysis of the variant in the regulatory subunit of phosphoinositide 3‐kinase (p85α) with Type 2 diabetes mellitus and hypertension in the Chinese Han population , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[43]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[44]  P. Rehak,et al.  Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma. , 2004, American journal of clinical pathology.

[45]  David S. Paul,et al.  Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. , 2004, Toxicology and applied pharmacology.

[46]  E. Feskens,et al.  The insulin receptor substrate‐1 Gly972Arg polymorphism is not associated with Type 2 diabetes mellitus in two population‐based studies , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[47]  C. Tseng.  The potential biological mechanisms of arsenic-induced diabetes mellitus. , 2004, Toxicology and applied pharmacology.

[48]  Y. Hsueh,et al.  Urinary arsenic speciation in subjects with or without restriction from seafood dietary intake. , 2002, Toxicology letters.

[49]  E. Bonora,et al.  Predictors of insulin sensitivity in Type 2 diabetes mellitus , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[50]  H. Klein,et al.  Delays in insulin signaling towards glucose disposal in human skeletal muscle. , 2002, The Journal of endocrinology.

[51]  D. Schlundt,et al.  Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American children. , 2001, Diabetes care.

[52]  M. Lewitt.  Stimulation of IGF-binding protein-1 secretion by AMP-activated protein kinase. , 2001, Biochemical and biophysical research communications.

[53]  M. Stampfer,et al.  Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. , 2001, The Journal of clinical endocrinology and metabolism.

[54]  R. Baxter.  Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. , 2000, American journal of physiology. Endocrinology and metabolism.

[55]  C. Kahn,et al.  Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. , 2000, The Journal of clinical investigation.

[56]  X. Le,et al.  Excretion of arsenic in urine as a function of exposure to arsenic in drinking water. , 1999, Environmental health perspectives.

[57]  Y. Hsueh,et al.  Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[58]  T. Hansen,et al.  Identification of a Common Amino Acid Polymorphism in the p85α Regulatory Subunit of Phosphatidylinositol 3-Kinase: Effects on Glucose Disappearance Constant, Glucose Effectiveness, and the Insulin Sensitivity Index , 1997, Diabetes.

[59]  C. Stewart,et al.  Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. , 1996, Physiological reviews.

[60]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[61]  M. Lai,et al.  Ingested inorganic arsenic and prevalence of diabetes mellitus. , 1994, American journal of epidemiology.

[62]  S Lemeshow,et al.  Confidence interval estimation of interaction. , 1992, Epidemiology.

[63]  C. Larsson,et al.  Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7. , 1992, Genomics.

[64]  D. Powell,et al.  Insulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activity. , 1990, The Journal of biological chemistry.

[65]  C. J. Chen,et al.  Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. , 1985, Cancer research.

[66]  S. Fuhrman,et al.  Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.

[67]  J. Manson,et al.  Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women , 2013, Diabetologia.

[68]  Y. Hsueh,et al.  The relationship between obesity, insulin and arsenic methylation capability in Taiwan adolescents. , 2012, The Science of the total environment.

[69]  D. Corella.  Alcohol intake. , 2012, Progress in molecular biology and translational science.

[70]  R. Gemmill,et al.  Obesity, cholesterol, and clear-cell renal cell carcinoma (RCC). , 2010, Advances in cancer research.